国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mycobacterium smegmatis F420-dependent glucose-6-phosphate dehydrogenase (fgd) CSB-YP371036MVX
CSB-EP371036MVX
CSB-BP371036MVX
CSB-MP371036MVX
CSB-EP371036MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis Thiazole synthase (thiG) CSB-YP371037MVX
CSB-EP371037MVX
CSB-BP371037MVX
CSB-MP371037MVX
CSB-EP371037MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP371038MVX
CSB-EP371038MVX
CSB-BP371038MVX
CSB-MP371038MVX
CSB-EP371038MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis Signal-transduction histidine kinase senX3 (senX3) CSB-YP371039MVX
CSB-EP371039MVX
CSB-BP371039MVX
CSB-MP371039MVX
CSB-EP371039MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP371040MVX
CSB-EP371040MVX
CSB-BP371040MVX
CSB-MP371040MVX
CSB-EP371040MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 1,4-Dihydroxy-2-naphthoyl-CoA synthase (menB) CSB-YP371041MVX
CSB-EP371041MVX
CSB-BP371041MVX
CSB-MP371041MVX
CSB-EP371041MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis Demethylmenaquinone methyltransferase (ubiE) CSB-YP371042MVX
CSB-EP371042MVX
CSB-BP371042MVX
CSB-MP371042MVX
CSB-EP371042MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis UPF0234 protein MSMEG_1165 (MSMEG_1165) CSB-YP371043MVX
CSB-EP371043MVX
CSB-BP371043MVX
CSB-MP371043MVX
CSB-EP371043MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L33 1 (rpmG1) CSB-YP371044MVX
CSB-EP371044MVX
CSB-BP371044MVX
CSB-MP371044MVX
CSB-EP371044MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP371045MVX
CSB-EP371045MVX
CSB-BP371045MVX
CSB-MP371045MVX
CSB-EP371045MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L3 (rplC) CSB-YP371046MVX
CSB-EP371046MVX
CSB-BP371046MVX
CSB-MP371046MVX
CSB-EP371046MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L2 (rplB) CSB-YP371047MVX
CSB-EP371047MVX
CSB-BP371047MVX
CSB-MP371047MVX
CSB-EP371047MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 30S ribosomal protein S19 (rpsS) CSB-YP371048MVX
CSB-EP371048MVX
CSB-BP371048MVX
CSB-MP371048MVX
CSB-EP371048MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L14 (rplN) CSB-YP371049MVX
CSB-EP371049MVX
CSB-BP371049MVX
CSB-MP371049MVX
CSB-EP371049MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 30S ribosomal protein S8 (rpsH) CSB-YP371050MVX
CSB-EP371050MVX
CSB-BP371050MVX
CSB-MP371050MVX
CSB-EP371050MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L30 (rpmD) CSB-YP371051MVX
CSB-EP371051MVX
CSB-BP371051MVX
CSB-MP371051MVX
CSB-EP371051MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis Putative S-adenosyl-L-methionine-dependent methyltransferase MSMEG_1482 (MSMEG_1482) CSB-YP371052MVX
CSB-EP371052MVX
CSB-BP371052MVX
CSB-MP371052MVX
CSB-EP371052MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L36 (rpmJ) CSB-YP371053MVX
CSB-EP371053MVX
CSB-BP371053MVX
CSB-MP371053MVX
CSB-EP371053MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 30S ribosomal protein S11 (rpsK) CSB-YP371054MVX
CSB-EP371054MVX
CSB-BP371054MVX
CSB-MP371054MVX
CSB-EP371054MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium smegmatis 50S ribosomal protein L13 (rplM) CSB-YP371055MVX
CSB-EP371055MVX
CSB-BP371055MVX
CSB-MP371055MVX
CSB-EP371055MVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>